These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29797530)

  • 1. Case of xeroderma pigmentosum group A with West syndrome.
    Nakao A; Tanizaki H; Yu A; Araki A; Moriwaki S
    J Dermatol; 2018 Dec; 45(12):e334-e336. PubMed ID: 29797530
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological manifestations of xeroderma pigmentosum due to
    Salomão RPA; Pedroso JL; Barsottini OGP
    Pract Neurol; 2018 Dec; 18(6):489-491. PubMed ID: 30077970
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
    Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
    Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of XP complementation groups by recombinant adenovirus carrying DNA repair genes.
    Leite RA; Marchetto MC; Muotri AR; Vasconcelos Dde M; de Oliveira ZN; Machado MC; Menck CF
    J Invest Dermatol; 2009 Feb; 129(2):502-6. PubMed ID: 18685619
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of genotype-phenotype correlation in xeroderma pigmentosum.
    Fassihi H
    Br J Dermatol; 2015 Apr; 172(4):859-60. PubMed ID: 25827741
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel XPA splice-site mutation identified in a 4-year-old Filipino girl with xeroderma pigmentosum.
    Reyes HH; Lin YC; Hsu CK; Guevara BEK
    Australas J Dermatol; 2023 May; 64(2):e165-e167. PubMed ID: 36866916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum.
    Jung EG
    Int J Dermatol; 1986 Dec; 25(10):629-33. PubMed ID: 3542861
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
    Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
    Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ancient origin of a Japanese xeroderma pigmentosum founder mutation.
    Imoto K; Nadem C; Moriwaki S; Nishigori C; Oh KS; Khan SG; Goldstein AM; Kraemer KH
    J Dermatol Sci; 2013 Feb; 69(2):175-6. PubMed ID: 23194742
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
    Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xeroderma pigmentosum with versive seizures.
    Mimaki T; Ito N; Tagawa T; Yabuuchi H
    Pediatr Neurol; 1988; 4(1):58-61. PubMed ID: 3233108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
    Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
    Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer in xeroderma pigmentosum and related disorders of DNA repair.
    Cleaver JE
    Nat Rev Cancer; 2005 Jul; 5(7):564-73. PubMed ID: 16069818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare case of Cockayne syndrome with xeroderma pigmentosum.
    Bartenjev I; Butina MR; Potocnik M
    Acta Derm Venereol; 2000 May; 80(3):213-4. PubMed ID: 10954218
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed hypersensitivity in xeroderma pigmentosum.
    Salamon T; Stojaković M; Bogdanović B
    Arch Dermatol Forsch; 1975; 251(4):277-80. PubMed ID: 1119845
    [No Abstract]   [Full Text] [Related]  

  • 20. A Distinct Genotype of XP Complementation Group A: Surprisingly Mild Phenotype Highly Prevalent in Northern India/Pakistan/Afghanistan.
    Sethi M; Haque S; Fawcett H; Wing JF; Chandler N; Mohammed S; Frayling IM; Norris PG; McGibbon D; Young AR; Sarkany RPE; Lehmann AR; Fassihi H
    J Invest Dermatol; 2016 Apr; 136(4):869-872. PubMed ID: 26743599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.